Skip to content

Effect of time of doing exercise test on results of exercise test, Clinical trial effect of time of doing Exercise Test and Circadian Typology (Morningness-Eveningness) on results of exercise test and some of heart risk markers and electrolytes in patient with symptoms of Chronic Stable Angina

Clinical trial effect of time of doing Exercise Test and Circadian Typology (Morningness-Eveningness) on results of exercise test and some of heart risk markers and electrolytes in patient with symptoms of Chronic Stable Angina

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
IRCT
Registry ID
IRCT2017061834616N1
Enrollment
30
Registered
2017-08-10
Start date
2017-08-11
Completion date
Unknown
Last updated
2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chronic stable angina. Anginal syndrome Ischaemic chest pain

Interventions

Time of taking exercise test In the morning(8-10 am) In the afternoon(3-5 pm).
Time of taking exercise test In the morning(8-10 am) In the afternoon(3-5 pm)

Sponsors

Vice chancellor for research, Kashan University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
50 Years to 65 Years

Inclusion criteria

Inclusion criteria: Inclusion criteria: Patient with symptoms of chronic stable angina; Non others heart diseases (MI, Cardiomyopathy, Arythmie ); and kidney, cancer and breathing diseases; Non taking particular medicine drugs; Non surgery at 6 last months; Non taking multivitamins at 6 last months; No regular activity. Non sudden relative death at exercise Exclusion criteria: Being negative both exercise test results;.Taking special drugs;.Doing exercise ; Unnatural ECG before exercise test; Smoking and Alcohol drinking 24 hours before test

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
Sodium. Timepoint: Before and after exercise test. Method of measurement: Mmol.litre. Electrolyte analyzer.;MET. Timepoint: End of exercise test. Method of measurement: ml.kg.min. Recorded in the system.;Fibrinogen. Timepoint: Before and after exercise test. Method of measurement: mg/dl. Thrombotimer.;CRP. Timepoint: Before and after exercise test. Method of measurement: mg.dl.Thrombotimer.;Blood pressure. Timepoint: Bbefore and after exercise test. Method of measurement: mm.Hg. Recorded in the system.;Potassium. Timepoint: Before and after exercise test. Method of measurement: mmol.litre. Electrolyte analyzer.;Calcium. Timepoint: Before and after exercise test. Method of measurement: mmol.litre. Thrombotimer.;Homocysteine. Timepoint: Before and after exercise test. Method of measurement: µmol/L. Thrombotimer.;Distance. Timepoint: End of exercise test. Method of measurement: Meter. Recorded in the system.;ECG. Timepoint: During 0f exercise testing. Method of measurement: Change of ECG. Recorded in the system.;Heart rate. Timepoint: In During exercise test. Method of measurement: bpm. Recorded in the system.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactMaryam Mehrabi

Phd Student of Shahid Beheshti university in Tehran

Mehrabi.1764@gmail.com+98 31 5434 9353

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026